1 / 50

Surgical Breast Pathology

Surgical Breast Pathology. Juan C. Cendan, MD Assistant Professor of Surgery. Objectives of Lecture. Categorize risk factors for cancer Highlight future cancer risk for a given benign lesion Describe diagnostic workup for breast masses and tools available to the clinician

shay-cannon
Download Presentation

Surgical Breast Pathology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Surgical Breast Pathology Juan C. Cendan, MD Assistant Professor of Surgery

  2. Objectives of Lecture • Categorize risk factors for cancer • Highlight future cancer risk for a given benign lesion • Describe diagnostic workup for breast masses and tools available to the clinician • Provide up-to-date guidelines in the screening and diagnosis of breast masses • Brief review of surgical options and implications in patients with breast cancer

  3. Assessment of Risk/History • Four major risks (increase RR by 4x): • Family history • 1st degree relatives • Age at diagnosis, BRCA1/2 risk • Atypical hyperplasia on prior biopsies • Personal breast cancer history • LCIS

  4. Assessment of Risk/History • Four Minor Risk Factors: 1-2x RR • Early menarche • Long interval from menarche to 1st child • Nulliparity • Ovarian or endometrial cancer • Estrogen therapy after menopause

  5. Physical Exam • Be systematic • Inspection of breasts: sitting up, then recumbent • “Strip method” • Nipples • Lymph nodes

  6. Clinical Examination of a Patient with Benign Breast Disease Santen, R. J. et al. N Engl J Med 2005;353:275-285

  7. Common Benign Breast Disorders in Women Santen, R. J. et al. N Engl J Med 2005;353:275-285

  8. Diagnostics • Standard screening mammogram • CC and MLO • Diagnostic mammogram • Above, plus compression/additional views • In either case, 5-10% false negative and 90-95% sensitivity

  9. Cranio-caudal (CC) view and mediolateral oblique (MLO) mammographic view

  10. Atypical Hyperplasia

  11. Histopathological Appearance of Benign Breast Disease (Hematoxylin and Eosin) Panel A shows nonproliferative fibrocystic changes:the architecture of the terminal-duct lobular unit is distorted by the formation of microcysts,associated with interlobular fibrosis.Panel B shows proliferative hyperplasia without atypia. This is adenosis,a distinctive form of hyperplasia characterized by the proliferation of lobular acini,forming crowded gland-like structures.For comparison,a normal lobule is on the left side.Panel C also shows proliferative hyperplasia without atypia.This is moderate ductal hyperplasia,which is characterized by a duct that is partially distended by hyper- plastic epithelium within the lumen.Panel D again shows proliferative hyperplasia without atypia,but this is florid ductal hyperplasia:the involved duct is greatly expanded by a crowded,jumbled-appearing epithelial proliferation.Panel E shows atypical ductal hyperplasia:these proliferations are characterized by a combination of architectural complexity with partially formed secondary lumens and mild nuclear hyperchromasia in the epithelial-cell population.Panel F shows atypical lobular hyperplasia:monotonous cells fill the lumens of partially distended acini in this terminal-duct lob- ular unit. Hartmann, L. C. et al. N Engl J Med 2005;353:229-237

  12. Diagnostics • Ultrasound • Useful in the young • Useful in pregnant women • Delineates solid vs cystic • MRI • Possibly the future of breast diagnostics, not there yet, limitations with biopsy

  13. Solid (Suspicious) Breast Mass

  14. Cyst Fibroadenoma

  15. Biopsy techniques • Palpable solid mass • Needle or core biopsy • Incisional or excisional biopsy • Non-palpable mass • Stereotactic core • Stereotactic “mammotome” • Needle localized biopsy

  16. Some Benign Conditions • Nipple Discharge • Incidence of malignancy when bloody (10-15%) and unilateral, though usually papilloma • More likely cystic or duct ectasia • Consider prolactin if bilateral

  17. Benign, con’t • Fibroadenoma • Very common in young women • Freely mobile and smooth • Characteristic u/s appearance • Half of adenomas resolve if <3cm over 5yrs • Large adenomas should be biopsied to exclude rare phylloides tumor

  18. Benign, con’t • Cysts • Due to relative excess estrogen, usually in 4-5th decades • Fluctuate with menses • Aspirate, if bloody then excise, send fluid for path the first time

  19. Benign, con’t • Abscess, • Usually in lactating women • Painful and erythematous • Usually staph and strep • Drainage and antibiotics indicated • Rarely, can aspirate and treat with antibiotics • Caveats, in nonlactating (Ca), non-resolving (atypical infection), inflammatory cancer

  20. Classification of Benign Breast Lesions on Histologic Examination, According to the Relative Risk of Breast Cancer Santen, R. J. et al. N Engl J Med 2005;353:275-285

  21. Risk of Breast Cancer According to Breast Density in Premenopausal and Postmenopausal Women Santen, R. J. et al. N Engl J Med 2005;353:275-285

  22. Risk of cancer of benign breast lesions, Hartmann et al, NEJM 2005

  23. Gail, J Natl Cancer Inst. 1989 Dec 20;81(24):1879-86.

  24. Examples of Outcomes among 100 Women Followed for an Average of 15 Years: Explaining Relative Risk Calculations to Patients… Start with known risk and “translate” it to an absolute risk Elmore, J. G. et al. N Engl J Med 2005;353:297-299

  25. Cancer • Most women with breast cancer have no risk factors! • Role of dietary fat, estrogen • Breast cancer genes responsible for 3-5% only

  26. Cancer • DCIS • Carcinoma in situ • Usually found on mammography as microcalcifications • Felt to progress to invasive in 30-50% if untreated • Subtypes: comedo highest risk

  27. Cancer • DCIS, con’t • Treatment • Non-invasive, so risk of LN disease is minimal • Must treat the breast, options: • Excise with large enough margins (>1cm) in a small tumor • Or, Excise and radiate • Or, Mastectomy +/- reconstruction

  28. Cancer • Invasive Ductal Cancer • “Garden variety breast cancer” • More often presents with mass than DCIS • Treatment: • BREAST: Excise and RT or mastectomy, Cannot just excise with margins (30-40% recur) • Lymph Nodes: Must be sampled for staging • Sentinel Node vs Axillary Dissection

  29. Cancer • Chemotherapy • Recommended for tumors >1cm in most patients • Recommended if lymph nodes are positive • 8 recommended chemo protocols at this time!! • ER positivity and Tamoxifen

  30. Cancer • Survival

More Related